| Feasibility of continuous temperature monitoring in pediatric immunocompromised patients: A pilot study M Sampson, V Hickey, J Huber, PB Alonso, SM Davies, CE Dandoy Pediatric blood & cancer 66 (6), e27723, 2019 | 19 | 2019 |
| Outcomes of pediatric patients with therapy-related myeloid neoplasms A Sharma, S Huang, Y Li, RJ Brooke, I Ahmed, HB Allewelt, P Amrolia, ... Bone marrow transplantation 56 (12), 2997-3007, 2021 | 7 | 2021 |
| Reduced intensity vs myeloablative conditioning regimen for pediatric therapy-related myelodysplastic syndrome/acute myeloid leukemia A Sharma, RJ Brooke, NS Bhatt, Y Li, HB Allewelt, JJ Bies, JE Brondon, ... Biology of Blood and Marrow Transplantation 25 (3), S14-S15, 2019 | 4 | 2019 |
| Single Agent Rituximab for Treatment of Multifocal and Multiple Relapsed Pulmonary Inflammatory Myofibroblastic Tumor in an Adolescent Patient N Farris, E Janitz, M Sampson Authorea Preprints, 2024 | 3 | 2024 |
| The effect of age at diagnosis of type 1 von Willebrand disease on diagnostic laboratory values: A paediatric perspective. ME Sampson, D Cheng, M Recht, JH Fargo Haemophilia 27 (3), 2021 | 2 | 2021 |
| Ann Arbor Score predicts thrombotic microangiopathy but not graft-versus-host disease in pediatric bone marrow transplant recipients ME Sampson, A Lane, KE Lake, N Luebbering, CE Dandoy, SM Davies Biology of Blood and Marrow Transplantation 25 (3), S230-S231, 2019 | 2 | 2019 |
| Continuous Temperature Monitoring in the Inpatient Setting Using Temptraq M Sampson, V Hickey, J Huber, P Davila, J Eager, S Davies, C Dandoy Pediatric Blood & Cancer; Wiley: Hoboken, NJ, USA 65, 2018 | 1 | 2018 |
| Transplant-Associated Thrombotic Microangiopathy of the Bladder Mimics Infectious Hemorrhagic Cystitis N Farris, C Culbertson, M Keisling, M Sampson Transplantation and Cellular Therapy, Official Publication of the American …, 2023 | | 2023 |
| SINGLE AGENT RITUXIMAB FOR TREATMENT OF MULTIFOCAL PULMONARY MYOFIBROBLASTIC TUMOR N Farris, M Sampson PEDIATRIC BLOOD & CANCER 67, S131-S131, 2020 | | 2020 |
| REDUCED INTENSITY CONDITIONING FOR PEDIATRIC THERAPY-RELATED MYELODYSPLASTIC SYNDROME/ACUTE MYELOID LEUKEMIA IS ASSOCIATED WITH REDUCED NON-RELAPSE MORTALITY BUT NO IMPROVEMENT … A Sharma, RJ Brooke, NS Bhatt, Y Li, HB Allewelt, JJ Bies, JE Brondon, ... PEDIATRIC BLOOD & CANCER 66, 2019 | | 2019 |
| RANDOMIZED CONTROL TRIAL EVALUATING THE IMPACT OF XYLITOL ON ORAL HEALTH AND MICROBIOME IN PEDIATRIC HEMATOPOIETIC STEM CELL TRANSPLANT RECIPIENTS P Badia, H Andersen, DB Haslam, A Nelson, J El-Bietar, S Golkari, ... PEDIATRIC BLOOD & CANCER 65, 2018 | | 2018 |
| Differing Neonatal Presentations of Epsilon Gamma Delta Beta Thalassemia within a Family M Sampson, S Savelli, A Abou Tayoun PEDIATRIC BLOOD & CANCER 64, S89-S90, 2017 | | 2017 |
| The Effect of Age at Diagnosis of Type I Von Willebrand Disease on Diagnostic Lab Values: A Pediatric Perspective M Sampson, D Cheng, J Fargo PEDIATRIC BLOOD & CANCER 64, S10-S10, 2017 | | 2017 |
